Cargando…

The Effects of Fecal Donors with Different Feeding Patterns on Diarrhea in a Patient Undergoing Hematopoietic Stem Cell Transplantation

Almost 90% of patients undergoing hematopoietic stem cell transplantation (HSCT) experience diarrheal episodes, which represent a severe, often life-threatening complication for these patients. Although fecal microbiota transplantation (FMT) represents an alternative treatment option for infection-r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jianping, Ren, Guangxu, Li, Minghua, Lu, Peihua, Yi, Suqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462343/ https://www.ncbi.nlm.nih.gov/pubmed/31049232 http://dx.doi.org/10.1155/2019/4505238

Ejemplares similares

The fecal microbiota of healthy donor horses and geriatric recipients undergoing fecal microbial transplantation for the treatment of diarrhea
por: McKinney, Caroline A., et al.
Publicado: (2020)

Advances in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia
por: Nannya, Yasuhito, et al.
Publicado: (2022)

Donor–Recipient Story in Allogeneic Hematopoietic Stem Cell Transplantation
por: Kum, Elena, et al.
Publicado: (2021)

Donor specific HLA antibody in hematopoietic stem cell transplantation: Implications for donor selection
por: Krummey, Scott M., et al.
Publicado: (2022)

Fecal Microbiota Transplantation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Systematic Review
por: Pession, Andrea, et al.
Publicado: (2021)

A Randomized, Placebo-controlled Trial of Fidaxomicin for Prophylaxis of Clostridium difficile–associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation
por: Mullane, Kathleen M, et al.
Publicado: (2019)

Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?
por: Li, Jiali, et al.
Publicado: (2020)

Mycophenolate mofetil increases the risk of diarrhea in allogeneic hematopoietic stem cell transplantation recipients
por: Lin, Liangmo, et al.
Publicado: (2023)

The use of donor-derived veto cells in hematopoietic stem cell transplantation
por: Ophir, Eran, et al.
Publicado: (2012)

Donor Cell Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation
por: Khattab, Ahmed, et al.
Publicado: (2023)

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation From Different Donors in Recipients With Mucopolysaccharidosis
por: Qu, Yuhua, et al.
Publicado: (2022)

The Super-Donor Phenomenon in Fecal Microbiota Transplantation
por: Wilson, Brooke C., et al.
Publicado: (2019)

Iron Overload in Patients Undergoing Hematopoietic Stem Cell Transplantation
por: Pullarkat, Vinod
Publicado: (2010)

Oral changes in individuals undergoing hematopoietic stem cell transplantation()
por: Barrach, Regina Haddad, et al.
Publicado: (2014)

Effect of rehabilitation in patients undergoing hematopoietic stem cell transplantation
por: Takekiyo, Takahiro, et al.
Publicado: (2023)

Transient apoptosis inhibition in donor stem cells improves hematopoietic stem cell transplantation
por: Kollek, Matthias, et al.
Publicado: (2017)

Autoimmune hematological diseases following haploidentical donor hematopoietic stem cell transplant compared with matched sibling and unrelated donor
por: Lv, Weiran, et al.
Publicado: (2017)

Fecal Microbiota Transplant From Highly Feed Efficient Donors Affects Cecal Physiology and Microbiota in Low- and High-Feed Efficient Chickens
por: Metzler-Zebeli, Barbara U., et al.
Publicado: (2019)

Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation
por: Morin-Zorman, Sarah, et al.
Publicado: (2016)

The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
por: Ljungman, Per, et al.
Publicado: (2020)

Antibiotic-Induced Shifts in Fecal Microbiota Density and Composition during Hematopoietic Stem Cell Transplantation
por: Morjaria, Sejal, et al.
Publicado: (2019)

Challenges and costs of donor screening for fecal microbiota transplantations
por: Bénard, Mèlanie V., et al.
Publicado: (2022)

Cytomegalovirus in donors for fecal microbiota transplantation, the phantom menace?
por: Galpérine, Tatiana, et al.
Publicado: (2023)

Outcomes of patients with hematological malignancies who undergo unrelated donor hematopoietic stem cell transplantation with ATG-Fresenius versus ATG-Genzyme
por: Wang, Lu, et al.
Publicado: (2023)

Views of Patients Undergo Hematopoietic Stem Cell Transplantation on Their Basic Needs
por: Sayadi, Leila, et al.
Publicado: (2013)

The Perceived Threat in Adults with Leukemia Undergoing Hematopoietic Stem Cell Transplantation
por: Farsi, Zahra, et al.
Publicado: (2013)

Reproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an update
por: Guida, Maurizio, et al.
Publicado: (2016)

Resiliency, the Lived Experience of Patients Undergoing Hematopoietic Stem Cell Transplantation
por: Karimi Rozveh, Ali, et al.
Publicado: (2019)

Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation
por: Yuda, Sayako, et al.
Publicado: (2022)

The Fecal Microbiome in Cats with Diarrhea
por: Suchodolski, Jan S., et al.
Publicado: (2015)

Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation
por: Innes, Andrew J., et al.
Publicado: (2021)

Donor derived hematopoietic stem cell niche transplantation facilitates mixed chimerism mediated donor specific tolerance
por: Zhang, Wensheng, et al.
Publicado: (2023)

From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation
por: Nicco, Carole, et al.
Publicado: (2020)

Correction: The challenge of COVID-19 and hematopoietic cell transplantation: EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy
por: Ljungman, Per, et al.
Publicado: (2020)

Fecal Microbial and Metabolic Profiles in Dogs With Acute Diarrhea Receiving Either Fecal Microbiota Transplantation or Oral Metronidazole
por: Chaitman, Jennifer, et al.
Publicado: (2020)

The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children
por: Park, Meerim, et al.
Publicado: (2011)

Preimmunization of donor lymphocytes enhances antitumor immunity of autologous hematopoietic stem cell transplantation
por: Suzuki, Koji, et al.
Publicado: (2013)

MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomes
por: Pourhassan, H, et al.
Publicado: (2016)

Hematopoietic stem cell transplantation from matched unrelated donors in chronic granulomatous disease
por: Schuetz, C., et al.
Publicado: (2008)

Mobilization‐based transplantation of young‐donor hematopoietic stem cells extends lifespan in mice
por: Guderyon, Michael J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4tsr842khstsngijqkkl1sonhv